(S)-tert-butyl 2-(5-(4-chlorophenyl)-6,7-dimethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl)acetate, 98%, 50mg

6-Trifluoromethylnicotinamide, 99.0%, 100g

9,10-Dibromophenanthrene, 95.0%, 5g

4-METHYLPIPERAZINE-1-SULFONAMIDE, 95.0%, 250mg

(2S)-2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid, 98%, 5g

Ethyl (1R,4R)-4-(dibenzylamino)cyclohexane-1-carboxylate, 97%, 1g

N-Cbz-N'-Methylethylenediamine hydrochloride, 95.0%, 100mg

Incubadora Heratherm Protocol series Advanced Protocol con ventilador de circulación, 178 l, IMH180, 1 pieza

Methyl 2-(4-formylphenoxy)acetate, 95.0%, 1g

2',6'-Dichloro-3'-fluoroacetophenone>97.0%(GC)25g

1-(4,6-Dichloropyridin-3-yl)ethanone, 95.0%, 250mg

1-(2-aminoethyl)-N-(2-methoxyethyl)-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 95.0%, 500mg

2-(2,4-Dimethylthiazol-5-yl)acetonitrile, 95+%, 250mg